Clinical Trial of PCV24 in Infants Aged 2-23 Months

NCT06800261 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infectious Disease

Interventions

BIOLOGICAL: Sinovac PCV24
BIOLOGICAL: Prevnar®

Sponsor

Sinovac Life Sciences Co., Ltd.